Journals / SDÜ Tıp Fakültesi Dergisi / 2013 / Cilt: 20 - Sayı: 1

The Hepatitis B, Hepatitis C and human immunodeficiency virus seroprevalence of cardiac surgery patients

KALP CERRAHİSİ HASTALARINDA HEPATİT B, HEPATİT C VE İNSAN İMMÜN YETMEZLİK VİRÜSÜ SEROPREVALANSI

Pages
14–17
Publication Date
2013-03-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The seroprevalence of HBV was found to be lower, and the seroprevalence ofHCV was found to be similar in comparison to the general population in patients undergoing open heartsurgery in Abant Izzet Baysal University Hospital of Health Research and Practice and no antiHIV seropositivitywas detected

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Hepatitis B, Hepatitis C and human immunodeficiency virus seroprevalence of cardiac surgery patientsBackground: It is aimed to investigate the seroprevalence of HBsAg, antiHCV and antiHIV of patientsundergoing open heart surgery in our cardiovascular surgery clinic.
📊
Key Findings & Data:Methods: The medical records of 480patients who underwent elective or emergency open heart surgery between October 2006 - January 2012 inour clinic were retrospectively evaluated in terms of HBsAg, antiHCV and antiHIV.
💡
Conclusion & Impact:Conclusion: The seroprevalence of HBV was found to be lower, and the seroprevalence ofHCV was found to be similar in comparison to the general population in patients undergoing open heartsurgery in Abant Izzet Baysal University Hospital of Health Research and Practice and no antiHIV seropositivitywas detected
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:HBsAg · antiHCV · antiHIV

Abstract

The Hepatitis B, Hepatitis C and human immunodeficiency virus seroprevalence of cardiac surgery patientsBackground: It is aimed to investigate the seroprevalence of HBsAg, antiHCV and antiHIV of patientsundergoing open heart surgery in our cardiovascular surgery clinic. Methods: The medical records of 480patients who underwent elective or emergency open heart surgery between October 2006 - January 2012 inour clinic were retrospectively evaluated in terms of HBsAg, antiHCV and antiHIV. Statistical analysis ofcollected data was performed by using the SPSS software (15.0) with Student's t test and chi-square test.Results: Of the 480 patients included in the study, 320 (66.7%) were male and 160 (33.3%) were female. Themean age of men was 61±11 and the mean age of women was 59±14. Five (1%) patients were positive forHBsAg and 6 (1.2%) patients were positive for antiHCV. None of the patients had antiHIV positivity. Nostatistically significant difference was found between the male and female patients in terms of HBsAg,antiHBs, antiHCV, and antiHIV seropositivities (p = 0.547, p = 0.186, p = 0.975, p = 1.00 and p = 0.082,respectively). Conclusion: The seroprevalence of HBV was found to be lower, and the seroprevalence ofHCV was found to be similar in comparison to the general population in patients undergoing open heartsurgery in Abant Izzet Baysal University Hospital of Health Research and Practice and no antiHIV seropositivitywas detected

Özet

Amaç: Kalp Damar Cerrahisi kliniğimize başvuran ve açık kalp cerrahisi uygulanan hastalarda Hepatit B yüzey antijeni (HBsAg), Hepatit C antikorları (Anti- HCV) ve İnsan immun yetmezlik virüs antikorları (Anti-HIV) seroprevalansının araştırılması amaçlanmıştır. Materyal ve Metot: Kalp Damar Cerrahisi kliniğimizde Ekim 2006 - Ocak 2012 tarihleri arasında elektif ya da acil açık kalp cerrahisi uygulanan 480 hastanın kayıtları hasta dosyaları üzerinden HBsAg, Anti-HCV ve Anti-HIV açısından retrospektif olarak değerlendirildi. Toplanan verilerin istatistiksel olarak değerlendirilmesi SPSS (15.0) programında student t testi ve Ki-kare testi kullanılarak yapıldı. Bulgular: Çalışmaya alınan 480 hastanın 320 (%66,7)'si erkek, 160 (%33,3)'ı kadındı. Erkeklerin yaş ortalaması 61±11, kadınların 59±14 idi. Beş (%1) hastada HBsAg pozitif olarak bulundu. Anti-HCV pozitif 6 (%1.2) hasta tespit edildi. Hiçbir hastada HIV pozitifliğine rastlanmadı. Ameliyat edilen toplam 480 hasta kadın ve erkek olarak iki gruba ayırdığımızda iki grup arasında HBsAg, Anti-HCV, Anti-HIV ve yaş açısından istatistiksel olarak anlamlı bir fark saptanmadı (sırasıyla p=0.547, p=0.186, p=0,975, p=1.00 ve p=0.082) . Sonuç: Abant İzzet Baysal Üniversitesi Sağlık Araştırma ve Uygulama Hastanesi'nde açık kalp ameliyatı yapılan hastalarda HBV seroprevelansı genel populasyondan daha düşük, HCV seroprevalansı genel populasyonla aynıyken, HIV seropozitifliğine rastlanmamıştır.

🔖

Cite This Article

Erdem, K., Taş, T., Tekelioğlu, Ü., BUĞRA, O., AKKAYA, A., DEMİRHAN, A., KÜÇÜKBAYRAK, A., DAĞLAR, B. (2013). The Hepatitis B, Hepatitis C and human immunodeficiency virus seroprevalence of cardiac surgery patients. SDÜ Tıp Fakültesi Dergisi, Cilt: 20 - Sayı: 1, 14–17. https://ajindex.com/articles/799641

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Akçam Z, Akçam M, Coþkun M, Sünbül M. Hastane personelinin viral hepatitler ve hepatit B aþýsý ile ilgili bilgi düzeyinin deðerlendirilmesi. Viral Hepatit Derg 2003; 8:32–5. Polat M, Öðüt S, Orhan H, Sucaklý MB. Isparta ve Burdur’da çalýþan hemþirelerin hepatit B virüs enfeksiyonu konusundaki bilgi, tutum ve davranýþlarý. Viral Hepatit Derg 2006;11:89–94. Fry DE. Occupational risks of blood exposure in the operat-ing room. Am Surgeon 2007;73:637-46.
  2. Phillips EK, Owusu-Ofori A, Jagger J. Bloodborne patho-gen exposure risk among surgeons in Sub- Saharan Africa. Infect Control Hosp Epidemiol 2007; 28: 1334-6. Hoþoðlu S, Akalýn Þ, Sünbül M, Oktun M, Öztürk R. Pre-dictive factors for occupational bloodborne exposure in Turkish hospitals. Am J Infect Control 2009; 37: 65-9.
  3. Öner M, Güney A, Halýcý M, Argün M, Kafadar Ý. Ortopedik cerrahi uygulanan olgularda hepatit B ve Hepatit C prevalansý: 10 yýllýk retrospektif çalýþma. Genel Týp Derg 2007; 17:167-71. Uyanýk MH, Malçok HK, Aktaþ O. Kan Donörlerinde Hepatit B,Hepatit C ve HIV-1/2 Seroprevalansý. MJAU 2004; 36: 35–8. Kaygusuz ÖT. Kronik Hemodiyaliz Hastalarýnda HBsAg ve Anti-HBs Seroprevalansý. F.Ü. Sað. Bil. Derg. 2007; 21: 55 –7. Banak S, Yoldaþcan E, Kýlýç E. Adana ili yarý kýrsal alanda yaþayan 10 yaþ ve üzeri kiþilerde hepatit B virusu (HBsAg) ve anti-hepatit C virusu (anti-HCV) prevalansý ve etkileyen faktörler.Ýnfek Derg 2002;16:133–40. U.S Public Health Service. Updated U.S. Public Health Serviceguidelines fort he management of occupational exposures to HBV, HCV, and HIV and recommendations for post exposure prophylaxis. MMWR Recomm Rep 2003; 52:1–36. André FE. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990;8:74-80 Ýnci M, Aksebzeci AT, Yaðmur G, Kartal B, Emiroðlu M, Erdem Y. Hastane çalýþanlarýnda HBV, HCV ve HIV seropozitifliðinin araþtýrýlmasý. Türk Hijyen ve Deneysel Biyoloji Dergisi 2009;66:59-66. Ökten A. Türkiye’de kronik hepatit, siroz ve hepatosellüler karsinoma etiyolojisi. Güncel Gastroenterol. 2003;7:187-91.
  4. Karabay O, Serin E, Tamer A, Gökdoðan F, Alpteker H, Ozcan A, et al. Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiologic study. Turk J Gastroenterol. 2004;15:11-3. Kargý E, Külah C, Hosnuter M, Babuccu O, Tekerekoglu B, Tekin Ý. Plastik cerrahide hepatit B, hepatit C ve HIV enfeksiyonu riski. Düzce Týp Fakültesi Dergisi 2003; 5:14-7.
  5. Utkan A, Dayýcan A, Toyran A